What is Zeroharm Sciences?
Zeroharm Sciences is distinguished as India’s premier nano-formulated nutraceutical brand, offering a comprehensive suite of 100% plant-based natural health supplements. The company's product portfolio spans vitamins, minerals, and therapeutics, meticulously developed to enhance key health areas including immunity, energy levels, and weight management. By leveraging advanced nanotechnology, Zeroharm Sciences significantly boosts nutrient absorption and overall efficacy, catering to a growing demographic seeking integrated, science-backed wellness solutions. Their commitment lies in harmonizing scientific innovation with natural ingredients to foster sustainable health and empower individuals toward enduring well-being.
How much funding has Zeroharm Sciences raised?
Zeroharm Sciences has raised a total of $7.1M across 1 funding round:
Series A
$7.1M
Series A (2026): $7.1M with participation from Alkemi Venture Partners
Key Investors in Zeroharm Sciences
Alkemi Venture Partners
Alkemi Venture Partners is an early-stage growth investor with a specific focus on the Indian healthcare industry, aiming to support entrepreneurs and enhance consumer wellness.
What's next for Zeroharm Sciences?
The recent major enterprise-level funding positions Zeroharm Sciences for substantial scaling and market expansion. This strategic investment is anticipated to fuel advancements in their nanotechnology research, broaden their product development pipeline, and enhance their market penetration across India and potentially international markets. The company's focus on plant-based, scientifically validated supplements aligns with global wellness trends, suggesting a trajectory towards becoming a leader in the advanced nutraceutical sector. Future growth will likely involve strategic partnerships and continued innovation to meet the evolving demands for effective, natural health solutions.
See full Zeroharm Sciences company page
